Stay updated on Opregen in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.

Latest updates to the Opregen in Geographic Atrophy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedCore content updated to include a government funding notice and new revision/version, signaling a status update; previous versioning line items were replaced with newer ones.SummaryDifference5%

- Check28 days agoChange DetectedAdded new substudy description, updated eligibility and device usage role, expanded location list (and counts), and new scheduling/version details; removed previous locations count and non-interventional wording.SummaryDifference6%

- Check43 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.3%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%

- Check57 days agoChange DetectedThe web page has been updated to include a new facility name and location details, along with a list of relevant publications, while removing several location-related terms and previous MedlinePlus topics.SummaryDifference8%

- Check64 days agoChange DetectedThe web page has been updated to reflect a new study on subretinal surgical delivery and the activity of OpRegen, with changes in the study's timeline, locations, and eligibility criteria. Notably, the number of study locations has increased from 9 to 11, and the study dates have been updated to August 2025.SummaryDifference21%

Stay in the know with updates to Opregen in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.